Hims & Hers Health
HIMS
139 hedge funds and large institutions have $497M invested in Hims & Hers Health in 2022 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 42 increasing their positions, 33 reducing their positions, and 23 closing their positions.
162% more call options, than puts
Call options by funds: $6.99M | Put options by funds: $2.66M
27% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 33
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
5.01% more ownership
Funds ownership: 50.26% → 55.27% (+5%)
4% more funds holding
Funds holding: 134 → 139 (+5)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
6% less capital invested
Capital invested by funds: $527M → $497M (-$30.3M)
Top Buyers
| 1 |
BlackRock
New York
|
+$26.4M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.13M |
| 3 |
JGC
J. Goldman & Co
New York
|
+$6.85M |
| 4 |
State Street
Boston,
Massachusetts
|
+$6.61M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.81M |
Top Sellers
| 1 |
TCMNY
Thrive Capital Management (New York)
New York
|
-$17.1M |
| 2 |
Millennium Management
New York
|
-$5.5M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.72M |
| 4 |
Morgan Stanley
New York
|
-$2.23M |
| 5 |
HF
HRT Financial
New York
|
-$2.15M |
HIMS Hedge Fund Activity: Q2 2022 in Review
139 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Hims & Hers Health (HIMS) for Q2 2022, worth a combined $497M — down 5.8% from $527M a quarter earlier.
Buyers outnumbered sellers: 29 funds opened new HIMS positions and 23 closed out — a net gain of 6 holders — while 42 added to existing stakes and 33 trimmed.
The largest buyer was BlackRock, adding an estimated $26.4M. The largest seller was Thrive Capital Management (New York), exiting entirely with an estimated $17.1M sold.
- 139 institutional investors held Hims & Hers Health (HIMS) as of Q2 2022, up from 134 in Q1 2022.
- Funds reported $497M of Hims & Hers Health stock for Q2 2022, down 5.8% quarter-over-quarter.
- 29 funds opened new Hims & Hers Health positions in Q2 2022 and 23 closed out, a net change of +6 holders.
- The largest Hims & Hers Health buyer in Q2 2022 was BlackRock, an estimated $26.4M added.
- The largest Hims & Hers Health seller in Q2 2022 was Thrive Capital Management (New York), an estimated $17.1M sold.
Based on aggregated 13F filings for Q2 2022.